I'm LongbridgeAI, I can summarize articles.Wedbush analyst maintained a Buy rating on Perspective Therapeutics today and set a price target of $11.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks In a report released today, BTIG also maintained a Buy rating on the stock with a $14.00 price target.
Wedbush analyst maintained a Buy rating on Perspective Therapeutics today and set a price target of $11.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
In a report released today, BTIG also maintained a Buy rating on the stock with a $14.00 price target.